Kevin Winthrop, MD, MPH, is a professor of infectious disease and ophthalmology at Oregon Health and Science University (OHSU) who also specializes in rheumatology. He was formerly an infectious disease epidemiologist in the division of tuberculosis elimination at the Centers for Disease Control and Prevention (CDC) and has coauthored numerous research papers and academic publications. As a primary and senior investigator in many clinical and epidemiologic studies in these fields, he has collaborated closely with the rheumatology community on the evaluation and prevention of opportunistic infections.
June 9th, 2020 | 21 mins 49 secs
ankylosing spondylitis, antibody tests, arthritis, axial spondylitis, biologics, coronavirus, covid testing, covid-19, dmards, high risk covid, hydroxychloroquine, immunocompromised, immunosuppressed, infection, infectious disease, osteoarthritis, prednisone, prevention, psoriatic arthritis, research, rheumatic diseases, rheumatoid arthritis, rheumatology, social distancing, steroids, vaccines, washing hands, wearing a mask
As many people begin returning to work during this pandemic, those living with arthritis may be feeling an increase in anxiety and stress about the risks of contracting COVID-19. In this episode of the Live Yes! With Arthritis Podcast, Dr. Kevin Winthrop, a leading expert in infectious disease and rheumatology, provides an update on what we now know– and still don’t know – about this new coronavirus and its effects on people with arthritis. He shares the latest information about the research, risks, testing and the future of potential vaccines.
Visit the Live Yes! With Arthritis Podcast site to read the blog, get show notes and a full transcript: https://arthritis.org/liveyes/podcast
We want to hear from you. Tell us what you think about the Live Yes! With Arthritis Podcast. Get started here: https://arthritisfoundation.az1.qualtrics.com/jfe/form/SV_ebqublsylCl7BIh